Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: A systematic literature search on 5 candidate biomarkers

Silje W. Syversen, Robert Landewe, Désirée Van Der Heijde, Joan M. Bathon, Maarten Boers, Vivian P. Bykerk, Oliver Fitzgerald, Dafna D. Gladman, Patrick Garnero, Piet Geusens, Hani El-Gabalawy, Robert D. Inman, Virginia Kraus, Tore K. Kvien, Philip J. Mease, Mikkel Østergaard, Christopher J. Ritchlin, Paul Peter Tak, William J. Taylor, Walter P. Maksymowych

Research output: Contribution to journalArticle

Abstract

Objective. To test the OMERACT 8 draft validation criteria for soluble biomarkers by assessing the strength of literature evidence in support of 5 candidate biomarkers. Methods. A systematic literature search was conducted on the 5 soluble biomarkers RANKL, osteoprotegerin (OPG), matrix metalloprotease (MMP-3), urine C-telopeptide of types I and II collagen (U-CTX-I and U CTX-II), focusing on the 14 OMERACT 8 criteria. Two electronic voting exercises were conducted to address: (1) strength of evidence for each biomarker as reflecting structural damage according to each individual criterion and the importance of each individual criterion; (2) overall strength of evidence in support of each of the 5 candidate biomarkers as reflecting structural damage endpoints in rheumatoid arthritis (RA) and identification of omissions to the criteria set. Results. The search identified 111 articles. The strength of evidence in support of these biomarkers reflecting structural damage was low for all biomarkers and was rated highest for U-CTX-II [score of 6.5 (numerical rating scale 0-10)]. The lowest scores for retention of specific criteria in the draft set went to criteria that refer to the importance of animal studies, correlations with other biomarkers reflecting damage, and an understanding of the metabolism of the biomarker. Conclusion. Evidence in support of any of the 5 tested biomarkers (MMP-3, CTX-I, CTX-II, OPG, RANKL) was inadequate to allow their substitution for radiographic endpoints in RA. Three of the criteria in the draft criteria set might not be required, but few omissions were identified. The Journal of Rheumatology

Original languageEnglish (US)
Pages (from-to)1769-1784
Number of pages16
JournalJournal of Rheumatology
Volume36
Issue number8
DOIs
StatePublished - Aug 2009

Fingerprint

Rheumatoid Arthritis
Biomarkers
Osteoprotegerin
Matrix Metalloproteinases
Collagen Type II
Rheumatology
Metalloproteases
Politics
Collagen Type I
Urine

Keywords

  • Biomarkers
  • Radiography
  • Rheumatoid arthritis
  • Structural damage
  • Validation

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis : A systematic literature search on 5 candidate biomarkers. / Syversen, Silje W.; Landewe, Robert; Van Der Heijde, Désirée; Bathon, Joan M.; Boers, Maarten; Bykerk, Vivian P.; Fitzgerald, Oliver; Gladman, Dafna D.; Garnero, Patrick; Geusens, Piet; El-Gabalawy, Hani; Inman, Robert D.; Kraus, Virginia; Kvien, Tore K.; Mease, Philip J.; Østergaard, Mikkel; Ritchlin, Christopher J.; Tak, Paul Peter; Taylor, William J.; Maksymowych, Walter P.

In: Journal of Rheumatology, Vol. 36, No. 8, 08.2009, p. 1769-1784.

Research output: Contribution to journalArticle

Syversen, SW, Landewe, R, Van Der Heijde, D, Bathon, JM, Boers, M, Bykerk, VP, Fitzgerald, O, Gladman, DD, Garnero, P, Geusens, P, El-Gabalawy, H, Inman, RD, Kraus, V, Kvien, TK, Mease, PJ, Østergaard, M, Ritchlin, CJ, Tak, PP, Taylor, WJ & Maksymowych, WP 2009, 'Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: A systematic literature search on 5 candidate biomarkers', Journal of Rheumatology, vol. 36, no. 8, pp. 1769-1784. https://doi.org/10.3899/jrheum.090262
Syversen, Silje W. ; Landewe, Robert ; Van Der Heijde, Désirée ; Bathon, Joan M. ; Boers, Maarten ; Bykerk, Vivian P. ; Fitzgerald, Oliver ; Gladman, Dafna D. ; Garnero, Patrick ; Geusens, Piet ; El-Gabalawy, Hani ; Inman, Robert D. ; Kraus, Virginia ; Kvien, Tore K. ; Mease, Philip J. ; Østergaard, Mikkel ; Ritchlin, Christopher J. ; Tak, Paul Peter ; Taylor, William J. ; Maksymowych, Walter P. / Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis : A systematic literature search on 5 candidate biomarkers. In: Journal of Rheumatology. 2009 ; Vol. 36, No. 8. pp. 1769-1784.
@article{412c6d95e71943869e1e5f7969a52973,
title = "Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: A systematic literature search on 5 candidate biomarkers",
abstract = "Objective. To test the OMERACT 8 draft validation criteria for soluble biomarkers by assessing the strength of literature evidence in support of 5 candidate biomarkers. Methods. A systematic literature search was conducted on the 5 soluble biomarkers RANKL, osteoprotegerin (OPG), matrix metalloprotease (MMP-3), urine C-telopeptide of types I and II collagen (U-CTX-I and U CTX-II), focusing on the 14 OMERACT 8 criteria. Two electronic voting exercises were conducted to address: (1) strength of evidence for each biomarker as reflecting structural damage according to each individual criterion and the importance of each individual criterion; (2) overall strength of evidence in support of each of the 5 candidate biomarkers as reflecting structural damage endpoints in rheumatoid arthritis (RA) and identification of omissions to the criteria set. Results. The search identified 111 articles. The strength of evidence in support of these biomarkers reflecting structural damage was low for all biomarkers and was rated highest for U-CTX-II [score of 6.5 (numerical rating scale 0-10)]. The lowest scores for retention of specific criteria in the draft set went to criteria that refer to the importance of animal studies, correlations with other biomarkers reflecting damage, and an understanding of the metabolism of the biomarker. Conclusion. Evidence in support of any of the 5 tested biomarkers (MMP-3, CTX-I, CTX-II, OPG, RANKL) was inadequate to allow their substitution for radiographic endpoints in RA. Three of the criteria in the draft criteria set might not be required, but few omissions were identified. The Journal of Rheumatology",
keywords = "Biomarkers, Radiography, Rheumatoid arthritis, Structural damage, Validation",
author = "Syversen, {Silje W.} and Robert Landewe and {Van Der Heijde}, D{\'e}sir{\'e}e and Bathon, {Joan M.} and Maarten Boers and Bykerk, {Vivian P.} and Oliver Fitzgerald and Gladman, {Dafna D.} and Patrick Garnero and Piet Geusens and Hani El-Gabalawy and Inman, {Robert D.} and Virginia Kraus and Kvien, {Tore K.} and Mease, {Philip J.} and Mikkel {\O}stergaard and Ritchlin, {Christopher J.} and Tak, {Paul Peter} and Taylor, {William J.} and Maksymowych, {Walter P.}",
year = "2009",
month = "8",
doi = "10.3899/jrheum.090262",
language = "English (US)",
volume = "36",
pages = "1769--1784",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "8",

}

TY - JOUR

T1 - Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis

T2 - A systematic literature search on 5 candidate biomarkers

AU - Syversen, Silje W.

AU - Landewe, Robert

AU - Van Der Heijde, Désirée

AU - Bathon, Joan M.

AU - Boers, Maarten

AU - Bykerk, Vivian P.

AU - Fitzgerald, Oliver

AU - Gladman, Dafna D.

AU - Garnero, Patrick

AU - Geusens, Piet

AU - El-Gabalawy, Hani

AU - Inman, Robert D.

AU - Kraus, Virginia

AU - Kvien, Tore K.

AU - Mease, Philip J.

AU - Østergaard, Mikkel

AU - Ritchlin, Christopher J.

AU - Tak, Paul Peter

AU - Taylor, William J.

AU - Maksymowych, Walter P.

PY - 2009/8

Y1 - 2009/8

N2 - Objective. To test the OMERACT 8 draft validation criteria for soluble biomarkers by assessing the strength of literature evidence in support of 5 candidate biomarkers. Methods. A systematic literature search was conducted on the 5 soluble biomarkers RANKL, osteoprotegerin (OPG), matrix metalloprotease (MMP-3), urine C-telopeptide of types I and II collagen (U-CTX-I and U CTX-II), focusing on the 14 OMERACT 8 criteria. Two electronic voting exercises were conducted to address: (1) strength of evidence for each biomarker as reflecting structural damage according to each individual criterion and the importance of each individual criterion; (2) overall strength of evidence in support of each of the 5 candidate biomarkers as reflecting structural damage endpoints in rheumatoid arthritis (RA) and identification of omissions to the criteria set. Results. The search identified 111 articles. The strength of evidence in support of these biomarkers reflecting structural damage was low for all biomarkers and was rated highest for U-CTX-II [score of 6.5 (numerical rating scale 0-10)]. The lowest scores for retention of specific criteria in the draft set went to criteria that refer to the importance of animal studies, correlations with other biomarkers reflecting damage, and an understanding of the metabolism of the biomarker. Conclusion. Evidence in support of any of the 5 tested biomarkers (MMP-3, CTX-I, CTX-II, OPG, RANKL) was inadequate to allow their substitution for radiographic endpoints in RA. Three of the criteria in the draft criteria set might not be required, but few omissions were identified. The Journal of Rheumatology

AB - Objective. To test the OMERACT 8 draft validation criteria for soluble biomarkers by assessing the strength of literature evidence in support of 5 candidate biomarkers. Methods. A systematic literature search was conducted on the 5 soluble biomarkers RANKL, osteoprotegerin (OPG), matrix metalloprotease (MMP-3), urine C-telopeptide of types I and II collagen (U-CTX-I and U CTX-II), focusing on the 14 OMERACT 8 criteria. Two electronic voting exercises were conducted to address: (1) strength of evidence for each biomarker as reflecting structural damage according to each individual criterion and the importance of each individual criterion; (2) overall strength of evidence in support of each of the 5 candidate biomarkers as reflecting structural damage endpoints in rheumatoid arthritis (RA) and identification of omissions to the criteria set. Results. The search identified 111 articles. The strength of evidence in support of these biomarkers reflecting structural damage was low for all biomarkers and was rated highest for U-CTX-II [score of 6.5 (numerical rating scale 0-10)]. The lowest scores for retention of specific criteria in the draft set went to criteria that refer to the importance of animal studies, correlations with other biomarkers reflecting damage, and an understanding of the metabolism of the biomarker. Conclusion. Evidence in support of any of the 5 tested biomarkers (MMP-3, CTX-I, CTX-II, OPG, RANKL) was inadequate to allow their substitution for radiographic endpoints in RA. Three of the criteria in the draft criteria set might not be required, but few omissions were identified. The Journal of Rheumatology

KW - Biomarkers

KW - Radiography

KW - Rheumatoid arthritis

KW - Structural damage

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=67149135853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67149135853&partnerID=8YFLogxK

U2 - 10.3899/jrheum.090262

DO - 10.3899/jrheum.090262

M3 - Article

C2 - 19671812

AN - SCOPUS:67149135853

VL - 36

SP - 1769

EP - 1784

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 8

ER -